Forget About Social Determinants when Addressing Adherence to Topical Antipsoriatic Drugs
Saved in:
| Main Authors: | Mathias Tiedemann Svendsen, Klaus Ejner Andersen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2025-01-01
|
| Series: | Acta Dermato-Venereologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actadv/article/view/42698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisResearch in context
by: Khalaf Kridin, et al.
Published: (2025-01-01) -
Formulation and Assessment of Drug Release and Stability of New Antipsoriatic Emulgel
by: Azza Dawoud Hussien Dawoud, et al.
Published: (2025-03-01) -
The Pendulum of Adherence: An Interpretative Phenomenological Analysis of Psoriasis Treatment Discontinuation
by: Xiao Z, et al.
Published: (2025-07-01) -
User's adherence to hypertensive drug therapy
by: Zélia Maria de Sousa Araújo Santos, et al.
Published: (2013-02-01) -
Evaluation of Drug Adherence in Older Adults With Polypharmac
by: Farideh Bastani, et al.
Published: (2024-06-01)